Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (910)	9/19/1999 6:56:00 PM
From: Larry S.	Read Replies (1) \| Respond to of 5582

I Quit !!! Removing GUMM from my subjectmarks. I have a small position in GUMM, and bookmarked this thread to follow developments. But these personal attacks completely detract from the reason i read and post to SI. Good luck guys, have fun in the gutter. Larry

To: Bill Wexler who wrote (910)	9/19/1999 6:58:00 PM
From: DanZ	Read Replies (1) \| Respond to of 5582

Bill, First, I didn't say that nobody could suspend zinc in a nasal gel. What I said, was it's not as easy as you purport. Big difference. In addition, there's no doubt that GumTech will protect their intellectual property rights if a competitor violates the patent. Second, you continue to waffle between Zicam is a fraud and competitors want their business; or Zicam will have zero retail sales and competitors want their business. So which is it, Bill? Why would competitors want to enter a fraudulent business that has zero retail sales?